Back to search results

Namodenoson Treatment of Advanced Pancreatic Cancer

IsraelRecruitingPHASE2

Conditions

Pancreatic Adenocarcinoma · Pancreatic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Rabin Medical Center Institute of Oncology, Petah Tikva, Israel

    Contact: Study coordinator (Salomon M Stemmer, MD)
Study leads

  • Michael H Silverman, MD

    Study Director

    Can-Fite BioPharma

  • Salomon M Stemmer, MD

    Principal Investigator

    Rabin Medical Center

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)